Floatz logo

ISOSORBIDE 5-MONONITRATE

Gastrointestinal Hemorrhage

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauSmall moleculePhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Gastrointestinal Hemorrhage cohort.

Asset / SponsorPhaseRating
NADOLOL
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Phase 4BB
PRAZOSIN
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Phase 4BB
Golytely
Santa Clara Valley Health & Hospital System
Phase 4BB
Prucalopride
University of British Columbia
Phase 4BB
Acetylsalicylic Acid
Maria Sklodowska-Curie National Research Institute of Oncology
Phase 4BB
Thalidomide
The Cleveland Clinic
Phase 3B
Rifaximin
Shanghai Zhongshan Hospital
N/AD

Same molecule, other indications

ISOSORBIDE 5-MONONITRATE is also rated in:

portal hypertensionDormant
BB
Indicative ·
65 / 100
View asset →
cirrhosis of liverDormant
B
Indicative ·
62 / 100
View asset →
ischemic strokeDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →